Phase 3 clinical trials are the crucial final step in the drug development process before a new medication can be approved by regulatory authorities for public use. These trials involve a large number of participants to further evaluate the safety and efficacy of the drug in comparison to existing treatments or a placebo. Phase 3 trials are designed to provide more comprehensive data on the drug's benefits, risks, and potential side effects, helping to determine if the medication is safe and effective for widespread use. Results from phase 3 trials play a significant role in shaping healthcare decisions and improving patient outcomes.